Brown Advisory Securities’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
NC
Brown Advisory Securities's TEVA Position: Q3 2017 in Review
Brown Advisory Securities sold out of Teva Pharmaceutical Industries (TEVA) in Q3 2017, closing a stake of 12,970 shares — an estimated $433K sold.
Brown Advisory Securities first reported a position in TEVA in Q1 2015 and held it in 9 quarters. The position peaked at $1.26M in Q1 2017. 536 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.
- Brown Advisory Securities reported no remaining Teva Pharmaceutical Industries position as of Q3 2017 after selling out during the quarter.
- Brown Advisory Securities sold 12,970 Teva Pharmaceutical Industries shares in Q3 2017, an estimated $433K.
- Brown Advisory Securities first reported a position in Teva Pharmaceutical Industries in Q1 2015 and held it in 9 quarters.
- Brown Advisory Securities's Teva Pharmaceutical Industries position peaked at $1.26M in Q1 2017.
- 536 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2017.
Based on Brown Advisory Securities's 13F filing for Q3 2017, filed 3 Nov 2017.